|
1
|
Lu G, Li Y, Ma Y, Lu J, Chen Y, Jiang Q,
Qin Q, Zhao L, Huang Q, Luo Z, et al: Long noncoding RNA LINC00511
contributes to breast cancer tumourigenesis and stemness by
inducing the miR-185-3p/E2F1/Nanog axis. J Exp Clin Cancer Res.
37:2892018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Xia W, Liu Y, Cheng T, Xu T, Dong M and Hu
X: Down-regulated lncRNA SBF2-AS1 inhibits tumorigenesis and
progression of breast cancer by sponging microRNA-143 and
repressing RRS1. J Exp Clin Cancer Res. 39:182020. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Corey B, Smania MA, Spotts H and Andersen
M: Young Women With Breast Cancer: Treatment, Care, and Nursing
Implications. Clin J Oncol Nurs. 24:139–147. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Guo Q, Lv S, Wang B, Li Y, Cha N, Zhao R,
Bao W and Jia B: Long non-coding RNA PRNCR1 has an oncogenic role
in breast cancer. Exp Ther Med. 18:4547–4554. 2019.PubMed/NCBI
|
|
5
|
Zhou Y, Meng X, Chen S, Li W, Li D, Singer
R and Gu W: IMP1 regulates UCA1-mediated cell invasion through
facilitating UCA1 decay and decreasing the sponge effect of UCA1
for miR-122-5p. Breast Cancer Res. 20:322018. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Huang Z, Zhou JK, Peng Y, He W and Huang
C: The role of long noncoding RNAs in hepatocellular carcinoma. Mol
Cancer. 19:772020. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Gugnoni M and Ciarrocchi A: Long Noncoding
RNA and Epithelial Mesenchymal Transition in Cancer. Int J Mol Sci.
20:202019. View Article : Google Scholar
|
|
8
|
Guo Q, Zhang Q, Lu L and Xu Y: Long
noncoding RNA RUSC1-AS1 promotes tumorigenesis in cervical cancer
by acting as a competing endogenous RNA of microRNA-744 and
consequently increasing Bcl-2 expression. Cell Cycle. 19:1222–1235.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Schmitt AM and Chang HY: Long Noncoding
RNAs in Cancer Pathways. Cancer Cell. 29:452–463. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Fan S, Yang Z, Ke Z, Huang K, Liu N, Fang
X and Wang K: Downregulation of the long non-coding RNA TUG1 is
associated with cell proliferation, migration, and invasion in
breast cancer. Biomed Pharmacother. 95:1636–1643. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zeng H, Wang J, Chen T, Zhang K, Chen J,
Wang L, Li H, Tuluhong D, Li J and Wang S: Downregulation of long
non-coding RNA Opa interacting protein 5-antisense RNA 1 inhibits
breast cancer progression by targeting sex-determining region Y-box
2 by microRNA-129-5p upregulation. Cancer Sci. 110:289–302.
2019.PubMed/NCBI
|
|
12
|
Davalos V and Esteller M: Disruption of
Long Noncoding RNAs Targets Cancer Hallmark Pathways in Lung
Tumorigenesis. Cancer Res. 79:3028–3030. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Hu CC, Liang YW, Hu JL, Liu LF, Liang JW
and Wang R: lncRNA RUSC1-AS1 promotes the proliferation of breast
cancer cells by epigenetic silence of KLF2 and CDKN1A. Eur Rev Med
Pharmacol Sci. 23:6602–6611. 2019.PubMed/NCBI
|
|
14
|
Yang G, Fu Y, Lu X, Wang M, Dong H and Li
Q: lncRNA HOTAIR/miR-613/c-met axis modulated
epithelial-mesenchymal transition of retinoblastoma cells. J Cell
Mol Med. 22:5083–5096. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Liang Y, Li Y, Song X, Zhang N, Sang Y,
Zhang H, Liu Y, Chen B, Zhao W, Wang L, et al: Long noncoding RNA
LINP1 acts as an oncogene and promotes chemoresistance in breast
cancer. Cancer Biol Ther. 19:120–131. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Shang Z, Yu J, Sun L, Tian J, Zhu S, Zhang
B, Dong Q, Jiang N, Flores-Morales A, Chang C, et al: lncRNA PCAT1
activates AKT and NF-κB signaling in castration-resistant prostate
cancer by regulating the PHLPP/FKBP51/IKKα complex. Nucleic Acids
Res. 47:4211–4225. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ding C, Wei R, Rodríguez RA and Del Mar
Requena Mullor M: lncRNA PCAT-1 plays an oncogenic role in
epithelial ovarian cancer by modulating cyclinD1/CDK4 expression.
Int J Clin Exp Pathol. 12:2148–2156. 2019.PubMed/NCBI
|
|
18
|
Zhen Q, Gao LN, Wang RF, Chu WW, Zhang YX,
Zhao XJ, Lv BL and Liu JB: lncRNA PCAT-1 promotes tumour growth and
chemoresistance of oesophageal cancer to cisplatin. Cell Biochem
Funct. 36:27–33. 2018. View
Article : Google Scholar : PubMed/NCBI
|
|
19
|
Huang L, Wang Y, Chen J, Wang Y, Zhao Y,
Wang Y, Ma Y, Chen X, Liu W, Li Z, et al: Long noncoding RNA PCAT1,
a novel serum-based biomarker, enhances cell growth by sponging
miR-326 in oesophageal squamous cell carcinoma. Cell Death Dis.
10:5132019. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Feng RM, Zong YN, Cao SM and Xu RH:
Current cancer situation in China: Good or bad news from the 2018
Global Cancer Statistics? Cancer Commun (Lond). 39:222019.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Tang R, Wu JC, Zheng LM, Li ZR, Zhou KL,
Zhang ZS, Xu DF and Chen C: Long noncoding RNA RUSC1-AS-N indicates
poor prognosis and increases cell viability in hepatocellular
carcinoma. Eur Rev Med Pharmacol Sci. 22:388–396. 2018.PubMed/NCBI
|
|
24
|
Shen WJ, Zhang F, Zhao X and Xu J: lncRNAs
and Esophageal Squamous Cell Carcinoma - Implications for
Pathogenesis and Drug Development. J Cancer. 7:1258–1264. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Hou J, Wang L, Wu Q, Zheng G, Long H, Wu
H, Zhou C, Guo T, Zhong T, Wang L, et al: Long noncoding RNA H19
upregulates vascular endothelial growth factor A to enhance
mesenchymal stem cells survival and angiogenic capacity by
inhibiting miR-199a-5p. Stem Cell Res Ther. 9:1092018. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Bi M, Yu H, Huang B and Tang C: Long
non-coding RNA PCAT-1 over-expression promotes proliferation and
metastasis in gastric cancer cells through regulating CDKN1A. Gene.
626:337–343. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wen J, Xu J, Sun Q, Xing C and Yin W:
Upregulation of long non coding RNA PCAT-1 contributes to cell
proliferation, migration and apoptosis in hepatocellular carcinoma.
Mol Med Rep. 13:4481–4486. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Li J, Li Y, Wang B, Ma Y and Chen P:
lncRNA-PCAT-1 promotes non-small cell lung cancer progression by
regulating miR-149-5p/LRIG2 axis. J Cell Biochem. Dec 19–2018.(Epub
ahead of print). doi: 10.1002/jcb.28046.
|
|
29
|
Li X, Deng S, Pang X, Song Y, Luo S, Jin L
and Pan Y: lncRNA NEAT1 Silenced miR-133b Promotes Migration and
Invasion of Breast Cancer Cells. Int J Mol Sci. 20:202019.
|
|
30
|
Chen L, Zhou Y and Li H: lncRNA, miRNA and
lncRNA-miRNA interaction in viral infection. Virus Res. 257:25–32.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Qin Q, Wei F, Zhang J and Li B: miR-134
suppresses the migration and invasion of non small cell lung cancer
by targeting ITGB1. Oncol Rep. 37:823–830. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Qin Q, Wei F, Zhang J, Wang X and Li B:
miR-134 inhibits non-small cell lung cancer growth by targeting the
epidermal growth factor receptor. J Cell Mol Med. 20:1974–1983.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Xie Y, Song J, Zong Q, Wang A, Yang Y, Liu
F and Meng X: Decreased Expression of MIR-134 and its Clinical
Significance in Human Colorectal Cancer. Hepatogastroenterology.
62:615–619. 2015.PubMed/NCBI
|
|
34
|
Zhang J, Ma Y, Wang S, Chen F and Gu Y:
C/EBPα inhibits proliferation of breast cancer cells via a novel
pathway of miR-134/CREB. Int J Clin Exp Pathol. 8:14472–14478.
2015.PubMed/NCBI
|
|
35
|
Pan JY, Zhang F, Sun CC, Li SJ, Li G, Gong
FY, Bo T, He J, Hua RX, Hu WD, et al: miR-134: A Human Cancer
Suppressor? Mol Ther Nucleic Acids. 6:140–149. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Acunzo J, Roche C, Defilles C, Thirion S,
Quentien MH, Figarella-Branger D, Graillon T, Dufour H, Brue T,
Pellegrini I, et al: Inactivation of PITX2 transcription factor
induced apoptosis of gonadotroph tumoral cells. Endocrinology.
152:3884–3892. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Hirose H, Ishii H, Mimori K, Tanaka F,
Takemasa I, Mizushima T, Ikeda M, Yamamoto H, Sekimoto M, Doki Y,
et al: The significance of PITX2 overexpression in human colorectal
cancer. Ann Surg Oncol. 18:3005–3012. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Zhang JX, Chen ZH, Xu Y, Chen JW, Weng HW,
Yun M, Zheng ZS, Chen C, Wu BL, Li EM, et al: Downregulation of
MicroRNA-644a Promotes Esophageal Squamous Cell Carcinoma
Aggressiveness and Stem Cell-like Phenotype via Dysregulation of
PITX2. Clin Cancer Res. 23:298–310. 2017. View Article : Google Scholar : PubMed/NCBI
|
